chartexchange

GNMSF
GENMAB A/S DKK
stockOTC

EODNov 17, 2026
515.00USD-0.103%(-0.53)500
Loading…
Loading…
Healthcare
Biotechnology
HQ
Copenhagen, Koebenhavn V, Denmark
Previous Close
$515.53
Beta
-0.42
52-Week High
$581.00 2026-10-28
52-Week Low
$232.34 2026-06-02
SMA 50
$374.87
SMA 200
$292.13
Avg. Vol 10D
2,768
Avg. Vol 30D
3,639
Avg. Vol 90D
3,088
Relative Vol
0.14
58.24M
GNMSF Profile

founded in 1999, genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer. partnering of selected product candidates and technologies is a key focus of genmab's strategy and the company has alliances with top tier pharmaceutical and biotechnology companies. disclaimer: bit.ly/gendisclaimer

GNMSF Performance
PeriodPriceDateChangeBeta
1W509.502026-11-12+1.08%-1.435
1M378.002026-10-19+36.24%-0.445
3M320.002026-08-18+60.94%-0.706
6M269.502026-05-20+91.09%-0.680
1Y306.002025-11-18+68.30%-0.423
2Y210.762024-11-18+144.35%—
5Y421.582021-11-18+22.16%-0.016
GNMSF Stock Summary

GENMAB A/S DKK (OTC:GNMSF) stock price today is $515.00, and today's volume is 500. GNMSF is down 0.103% today. The 30 day average volume is 3,639. GNMSF market cap is $34.06B with 66.14M shares outstanding.